Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
2
29%
Ph not_applicable
1
14%
Ph phase_1
4
57%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (57.1%)
Phase 22 (28.6%)
N/A1 (14.3%)

Trials by Status

terminated114%
completed457%
withdrawn114%
unknown114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance

NCT02621060
completedphase_2

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes

NCT02929901
unknownphase_1

Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer

NCT03751592
completedphase_1

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

NCT02245204
completedphase_1

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

NCT02728349
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02621060Phase 2

Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance

Completed
NCT02929901Phase 2

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes

Completed
NCT03751592Phase 1

Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer

Unknown
NCT02245204Phase 1

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Completed
NCT02728349Phase 1

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Completed
NCT02388672Not Applicable

Evaluation of Effects of Green Coffee Bean Extract (GCE) on Physiological and Psychological Variables

Withdrawn
NCT02136342Phase 1

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7